Eltrombo 25 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Eltrombo 25 mg Tablet contains eltrombopag and is described in its labelling for the treatment of low platelet counts, which can be caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection, and for severe aplastic anaemia. Platelets help blood clot and protect blood vessel walls; low platelet levels can cause severe bleeding and bruising. It is described as stimulating the sites that produce platelets, raising the platelet count and reducing bleeding and bruising. It is not suitable for people with hypersensitivity to the ingredients, and is not for patients under 18 with low platelet counts.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for low platelet counts caused by primary immune thrombocytopenia (ITP)
- Described for low platelet counts caused by hepatitis C virus (HCV) infection
- Described for severe aplastic anaemia
- Described as stimulating the platelet-producing sites to raise the platelet count and reduce bleeding and bruising
Described Dosage & Administration
- An oral medicine, taken in the dose and duration instructed by the doctor
- Can be taken with or without food; the tablet should not be chewed, broken, or crushed
- Swallowed with water and not with any other drink or alcohol
- The tablet should not be stopped even if the patient feels better, to allow full recovery
Described Side Effects
Commonly described side effects include:
- Nausea
- Diarrhoea and abdominal pain
- Common cold and cough
- High temperature
- Back pain
- Loss of appetite
- Hair loss
- Swelling in the feet or hands
- Headache and dizziness
These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The doctor should be informed about any current or past liver disease to avoid severe effects
- The doctor’s instructions on dosage, duration, and interval should be followed
- The doctor or healthcare team should be informed about pregnancy or breastfeeding, or if pregnancy occurs during treatment
- Not for patients under 18 years old with low platelet counts; stored at room temperature (25°C) and kept away from children and pets
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains eltrombopag and is used for low platelet counts caused by immune thrombocytopenia or hepatitis C, and for severe aplastic anaemia. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as an oral tablet swallowed whole with water — not chewed, broken, or crushed — with or without food, in the dose and duration instructed by the doctor, and not stopped early even if the patient feels better.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.